Evidence map›Paper›PMID 28079899›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2017

Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing.

Patricia Himes, Tia L Kauffman, Kristin R Muessig, Laura M Amendola, Jonathan S Berg, Michael O Dorschner, Marian Gilmore, Deborah A Nickerson, Jacob A Reiss, C Sue Richards and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Opportunistic genomic screening has clinical utility: An interventional cohort study.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
  9. Article
  10. Carrier screening for recessive disorders.Nature reviews. Genetics · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Patricia HimesDepartment of Medical Genetics, Kaiser Permanente Northwest, Portland, Oregon, USA.
Tia L KauffmanCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.ORCID 0000-0002-0419-4223
Kristin R MuessigCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.ORCID 0000-0001-9883-2224
Laura M AmendolaDepartment of Medicine, Division of Medical Genetics, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-5506-6168
Jonathan S BergDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA.ORCID 0000-0003-2360-2664
Michael O DorschnerDepartment of Pathology, University of Washington, Seattle, Washington, USA.
Marian GilmoreDepartment of Medical Genetics, Kaiser Permanente Northwest, Portland, Oregon, USA.ORCID 0000-0002-7177-683X
Deborah A NickersonDepartment of Genome Sciences, University of Washington, Seattle, Washington, USA.
Jacob A ReissCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
C Sue RichardsDepartment of Molecular and Medical Genetics, Oregon Health &Science University, Portland, Oregon, USA.ORCID 0000-0003-1078-979X
Alan F RopeNorthwest Permanente, Kaiser Permanente Northwest, Portland, Oregon, USA.ORCID 0000-0001-7926-4612
Dana K SimpsonNorthwest Permanente, Kaiser Permanente Northwest, Portland, Oregon, USA.ORCID 0000-0002-8812-8249
Benjamin S WilfondSeattle Children's Research Institute, Treuman Katz Center for Pediatric Bioethics, Seattle, Washington, USA.ORCID 0000-0002-2671-9860
Gail P JarvikDepartment of Medicine, Division of Medical Genetics, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-6710-8708
Katrina A B GoddardCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.ORCID 0000-0001-9535-8993
Kaiser Permanente · USKaiser Permanente Center for Health Research · USUniversity of Washington · USOregon Health & Science University · USSeattle Children's Hospital · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington Medical Center · US

Funding

North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing 2U01HG006487 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S, POWELL, BRADFORD C. · 2012 to 2021
$22.7M
Exome sequencing in Diverse Populations in Colorado & OregonU01HG007292 · NHGRI · KAISER FOUNDATION RESEARCH INSTITUTE · PI LEO, MICHAEL C, WILFOND, BENJAMIN SIMON · 2017 to 2021
$15.7M
Variation, Function, and Disease Supplement ProgramU01HG008657 · NHGRI · UNIVERSITY OF WASHINGTON · PI David Russell Crosslin, Gail Pairitz Jarvik · 2015 to 2026
$13.4M
Clinical Implementation of Carrier Testing using NGSUM1HG007292 · NHGRI · KAISER FOUNDATION RESEARCH INSTITUTE · PI GODDARD, KATRINA A., WILFOND, BENJAMIN SIMON · 2013 to 2016
$8.2M
Genetic Discovery and Application in a Clinical Setting Continuing a PartnershipU01HG006375 · NHGRI · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI JARVIK, GAIL PAIRITZ, LARSON, ERIC B · 2011 to 2014
$4.1M
CSER RoRC Centralized Support Coordinating CenterU01HG007307 · NHGRI · UNIVERSITY OF WASHINGTON · PI BURKE, WYLIE G., JARVIK, GAIL PAIRITZ · 2013 to 2016
$3.6M
NHGRI NIH HHS U01 HG006375NHGRI NIH HHS U01 HG006487NHGRI NIH HHS U01 HG007292NHGRI NIH HHS U01 HG007307NHGRI NIH HHS U01 HG008657NHGRI NIH HHS UM1 HG007292
6 · The paper itself

Abstract

purposeWe investigated the use of genome sequencing for preconception carrier testing. Genome sequencing could identify one or more of thousands of X-linked or autosomal recessive conditions that could be disclosed during preconception or prenatal counseling. Therefore, a framework that helps both clinicians and patients understand the possible range of findings is needed to respect patient preferences by ensuring that information about only the desired types of genetic conditions are provided to a given patient.

methodsWe categorized gene-condition pairs into groups using a previously developed taxonomy of genetic conditions. Patients could elect to receive results from these categories. A Return of Results Committee (RORC) developed inclusion and exclusion criteria for each category.

resultsTo date, the RORC has categorized 728 gene-condition pairs: 177 are categorized as life span-limiting, 406 are categorized as serious, 93 are categorized as mild, 41 are categorized as unpredictable, and 11 are categorized as adult-onset. An additional 64 gene-condition pairs were excluded from reporting to patients or put on a watch list, generally because evidence that a gene and condition were associated was limited.

conclusionCategorization of gene-condition pairs using our taxonomy simplifies communication regarding patient preferences for carrier information from a genomic test.Genet Med advance online publication 12 January 2017.

Indexed as

DisclosureExomeGenetic Carrier ScreeningGenetic TestingGenome, HumanGenomicsHumansIncidental FindingsPatient PreferenceSequence Analysis, DNA

Identifiers

PMID28079899
PMCPMC5509491
OpenAlexW2572054861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.